• Explore /
  • Poster
  • / Predicting treatment outcome of rectal cancer patients underwent neoadjuvant chemoradiotherapy by ctDNA: The potential use of ctDNA monitoring as organ-sparing approach.

Predicting treatment outcome of rectal cancer patients underwent neoadjuvant chemoradiotherapy by ctDNA: The potential use of ctDNA monitoring as organ-sparing approach.

Abstract Poster

Authors

null

Lifeng Yang

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

Lifeng Yang , Yaqi Wang , Lijun Shen , Juefeng Wan , Weijuan Deng , Ji Zhu , Zhen Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3608)

DOI

10.1200/JCO.2018.36.15_suppl.3608

Abstract #

3608

Poster Bd #

101

Abstract Disclosures

Similar Posters

First Author: Christina Sing-Ying Wu

Poster

2017 ASCO Annual Meeting

Clonal evolution in locally advanced rectal cancers in response to neoadjuvant chemoradiotherapy.

Clonal evolution in locally advanced rectal cancers in response to neoadjuvant chemoradiotherapy.

First Author: Sinead Toomey

First Author: Yoshinori Kagawa

First Author: Mian Xie